{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T10:29:51Z","timestamp":1794047391873,"version":"4.8.0"},"reference-count":50,"publisher":"Ferrata Storti Foundation (Haematologica)","issue":"6","license":[{"start":{"date-parts":[[2021,10,7]],"date-time":"2021-10-07T00:00:00Z","timestamp":1633564800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["haematol"],"abstract":"<jats:p>Platelet hyperreactivity and increased atherothrombotic risk are specifically associated with dyslipidemia. Peroxisome proliferator-activated receptor alpha (PPAR\u03b1) is an important regulator of lipid metabolism. It has been suggested to affect both thrombosis and hemostasis, yet the underlying mechanisms are not well understood. In this study, the role and mechanism of PPAR\u03b1 in platelet activation and thrombosis related to dyslipidemia were examined. Employing mice with deletion of PPAR\u03b1 (Ppar\u03b1-\/-), we demonstrated that PPARa is required for platelet activation and thrombus formation. The effect of PPAR\u03b1 is critically dependent on platelet dense granule secretion, and is contributed by p38MAPK\/Akt, fatty acid b-oxidation, and NAD(P)H oxidase pathways. Importantly, PPAR\u03b1 and the associated pathways mediated a prothrombotic state induced by a high-fat diet and platelet hyperactivity provoked by oxidized low density lipoproteins. Platelet reactivity was positively correlated with the levels of expression of PPAR\u03b1, as revealed by data from wild-type, chimeric (Ppar\u03b1+\/-), and Ppar\u03b1-\/- mice. This positive correlation was recapitulated in platelets from hyperlipidemic patients. In a lipid-treated megakaryocytic cell line, the lipid-induced reactive oxygen species-NF-kB pathway was revealed to upregulate platelet PPAR\u03b1 in hyperlipidemia. These data suggest that platelet PPAR\u03b1 critically mediates platelet activation and contributes to the prothrombotic status under hyperlipidemia.<\/jats:p>","DOI":"10.3324\/haematol.2021.279770","type":"journal-article","created":{"date-parts":[[2021,10,7]],"date-time":"2021-10-07T03:43:47Z","timestamp":1633578227000},"page":"1358-1373","source":"Crossref","is-referenced-by-count":37,"title":["Critical role of peroxisome proliferator-activated receptor \u03b1 in promoting platelet hyperreactivity and thrombosis under hyperlipidemia"],"prefix":"10.3324","volume":"107","author":[{"given":"Li","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiawei","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuai","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yangfan","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingke","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingqi","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zheyue","family":"Shu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank J.","family":"Gonzalez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aiming","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hu","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1856","published-online":{"date-parts":[[2021,10,7]]},"reference":[{"key":"36726","doi-asserted-by":"crossref","unstructured":"Skulas-Ray AC, Wilson PWF, Harris WS. Omega-3 fatty acids for the management of hypertriglyceridemia: a science advisory from the American Heart Association. Circulation. 2019; 140(12):e673-e691.","DOI":"10.1161\/CIR.0000000000000709"},{"key":"36727","doi-asserted-by":"crossref","unstructured":"Korporaal SJ, Meurs I, Hauer AD. Deletion of the high-density lipoprotein receptor scavenger receptor BI in mice modulates thrombosis susceptibility and indirectly affects platelet function by elevation of plasma free cholesterol. Arterioscler Thromb Vasc Biol. 2011; 31(1):34-42.","DOI":"10.1161\/ATVBAHA.110.210252"},{"key":"36728","doi-asserted-by":"crossref","unstructured":"Maschberger P, Bauer M, Baumann-Siemons J. Mildly oxidized low density lipoprotein rapidly stimulates via activation of the lysophosphatidic acid receptor Src family and Syk tyrosine kinases and Ca2+ influx in human platelets. J Biol Chem. 2000; 275(25):19159-19166.","DOI":"10.1074\/jbc.M910257199"},{"key":"36729","doi-asserted-by":"crossref","unstructured":"Cipollone F, Mezzetti A, Porreca E. Association between enhanced soluble CD40L and prothrombotic state in hypercholesterolemia: effects of statin therapy. Circulation. 2002; 106(4):399-402.","DOI":"10.1161\/01.CIR.0000025419.95769.F0"},{"key":"36730","doi-asserted-by":"crossref","unstructured":"Korporaal SJ, Gorter G, van Rijn HJ, Akkerman JW. Effect of oxidation on the platelet-activating properties of low-density lipoprotein. Arterioscler Thromb Vasc Biol. 2005; 25(4):867-872.","DOI":"10.1161\/01.ATV.0000158381.02640.4b"},{"key":"36731","doi-asserted-by":"crossref","unstructured":"Wraith KS, Magwenzi S, Aburima A, Wen Y, Leake D, Naseem KM. Oxidized low-density lipoproteins induce rapid platelet activation and shape change through tyrosine kinase and Rho kinase-signaling pathways. Blood. 2013; 122(4):580-589.","DOI":"10.1182\/blood-2013-04-491688"},{"key":"36732","doi-asserted-by":"crossref","unstructured":"Chen K, Febbraio M, Li W, Silverstein RL. A specific CD36-dependent signaling pathway is required for platelet activation by oxidized low-density lipoprotein. Circ Res. 2008; 102(12):1512-1519.","DOI":"10.1161\/CIRCRESAHA.108.172064"},{"key":"36733","doi-asserted-by":"crossref","unstructured":"Yang M, Cooley BC, Li W. Platelet CD36 promotes thrombosis by activating redox sensor ERK5 in hyperlipidemic conditions. Blood. 2017; 129(21):2917-2927.","DOI":"10.1182\/blood-2016-11-750133"},{"key":"36734","doi-asserted-by":"crossref","unstructured":"Magwenzi S, Woodward C, Wraith KS. Oxidized LDL activates blood platelets through CD36\/NOX2-mediated inhibition of the cGMP\/protein kinase G signaling cascade. Blood. 2015; 125(17):2693-2703.","DOI":"10.1182\/blood-2014-05-574491"},{"key":"36735","doi-asserted-by":"crossref","unstructured":"Moraes LA, Unsworth AJ, Vaiyapuri S. Farnesoid X receptor and its ligands inhibit the function of platelets. Arterioscler Thromb Vasc Biol. 2016; 36(12):2324-2333.","DOI":"10.1161\/ATVBAHA.116.308093"},{"key":"36736","doi-asserted-by":"crossref","unstructured":"Unsworth AJ, Bye AP, Tannetta DS. Farnesoid X receptor and liver X receptor ligands initiate formation of coated platelets. Arterioscler Thromb Vasc Biol. 2017; 37(8):1482-1493.","DOI":"10.1161\/ATVBAHA.117.309135"},{"key":"36737","doi-asserted-by":"crossref","unstructured":"Hashizume S, Akaike M, Azuma H. Activation of peroxisome proliferator-activated receptor alpha in megakaryocytes reduces platelet-derived growth factor-BB in platelets. J Atheroscler Thromb. 2011; 18(2):138-147.","DOI":"10.5551\/jat.5868"},{"key":"36738","doi-asserted-by":"crossref","unstructured":"Akbiyik F, Ray DM, Gettings KF, Blumberg N, Francis CW, Phipps RP. Human bone marrow megakaryocytes and platelets express PPARgamma, and PPARgamma agonists blunt platelet release of CD40 ligand and thromboxanes. Blood. 2004; 104(5):1361-1368.","DOI":"10.1182\/blood-2004-03-0926"},{"key":"36739","doi-asserted-by":"crossref","unstructured":"Ali FY, Davidson SJ, Moraes LA. Role of nuclear receptor signaling in platelets: antithrombotic effects of PPAR\u03b2eta. FASEB J. 2006; 20(2):326-328.","DOI":"10.1096\/fj.05-4395fje"},{"key":"36740","doi-asserted-by":"crossref","unstructured":"Gilde AJ, van der Lee KA, Willemsen PH. Peroxisome proliferator-activated receptor (PPAR) alpha and PPAR\u03b2eta\/delta, but not PPARgamma, modulate the expression of genes involved in cardiac lipid metabolism. Circ Res. 2003; 92(5):518-524.","DOI":"10.1161\/01.RES.0000060700.55247.7C"},{"key":"36741","doi-asserted-by":"crossref","unstructured":"Lalloyer F, Wouters K, Baron M. Peroxisome proliferator-activated receptor-alpha gene level differently affects lipid metabolism and inflammation in apolipoprotein E2 knock-in mice. Arterioscler Thromb Vasc Biol. 2011; 31(7):1573-1579.","DOI":"10.1161\/ATVBAHA.110.220525"},{"key":"36742","doi-asserted-by":"crossref","unstructured":"Badman MK, Pissios P, Kennedy AR, Koukos G, Flier JS, Maratos-Flier E. Hepatic fibroblast growth factor 21 is regulated by PPAR alpha and is a key mediator of hepatic lipid metabolism in ketotic states. Cell Metab. 2007; 5(6):426-437.","DOI":"10.1016\/j.cmet.2007.05.002"},{"key":"36743","doi-asserted-by":"crossref","unstructured":"Ali FY, Armstrong PC, Dhanji AR. Antiplatelet actions of statins and fibrates are mediated by PPARs. Arterioscler Thromb Vasc Biol. 2009; 29(5):706-711.","DOI":"10.1161\/ATVBAHA.108.183160"},{"key":"36744","doi-asserted-by":"crossref","unstructured":"Yeung J, Adili R, Yamaguchi A. Omega-6 DPA and its 12-lipoxygenase-oxidized lipids regulate platelet reactivity in a nongenomic PPAR\u03b1lpha-dependent manner. Blood Adv. 2020; 4(18):4522-4537.","DOI":"10.1182\/bloodadvances.2020002493"},{"key":"36745","doi-asserted-by":"crossref","unstructured":"Drosatos K, Pollak NM, Pol CJ. Cardiac myocyte KLF5 regulates Ppara expression and cardiac function. Circ Res. 2016; 118(2):241-253.","DOI":"10.1161\/CIRCRESAHA.115.306383"},{"key":"36746","doi-asserted-by":"crossref","unstructured":"Yu X, Li X, Zhao G. OxLDL up-regulates Niemann-Pick type C1 expression through ERK1\/2\/COX-2\/PPAR\u03b1lpha-signaling pathway in macrophages. Acta Biochim Biophys Sin (Shanghai). 2012; 44(2):119-128.","DOI":"10.1093\/abbs\/gmr119"},{"key":"36747","doi-asserted-by":"crossref","unstructured":"Sartippour MR, Renier G. Differential regulation of macrophage peroxisome proliferator-activated receptor expression by glucose : role of peroxisome proliferator-activated receptors in lipoprotein lipase gene expression. Arterioscler Thromb Vasc Biol. 2000; 20(1):104-110.","DOI":"10.1161\/01.ATV.20.1.104"},{"key":"36748","doi-asserted-by":"crossref","unstructured":"Lee SS, Pineau T, Drago J. Targeted disruption of the alpha isoform of the peroxisome proliferator-activated receptor gene in mice results in abolishment of the pleiotropic effects of peroxisome proliferators. Mol Cell Biol. 1995; 15(6):3012-3022.","DOI":"10.1128\/MCB.15.6.3012"},{"key":"36749","doi-asserted-by":"crossref","unstructured":"Jiang L, Xu C, Yu S. A critical role of thrombin\/PAR-1 in ADP-induced platelet secretion and the second wave of aggregation. J Thromb Haemost. 2013; 11(5):930-940.","DOI":"10.1111\/jth.12168"},{"key":"36750","doi-asserted-by":"crossref","unstructured":"Shi P, Zhang L, Zhang M. Platelet-specific p38alpha deficiency improved cardiac function after myocardial infarction in mice. Arterioscler Thromb Vasc Biol. 2017; 37(12):e185-e196.","DOI":"10.1161\/ATVBAHA.117.309856"},{"key":"36751","doi-asserted-by":"crossref","unstructured":"Arthur JF, Qiao J, Shen Y. ITAM receptor-mediated generation of reactive oxygen species in human platelets occurs via Syk-dependent and Syk-independent pathways. J Thromb Haemost. 2012; 10(6):1133-1141.","DOI":"10.1111\/j.1538-7836.2012.04734.x"},{"key":"36752","doi-asserted-by":"crossref","unstructured":"Lu Y, Harada M, Kamijo Y. Peroxisome proliferator-activated receptor alpha attenuates high-cholesterol diet-induced toxicity and pro-thrombotic effects in mice. Arch Toxicol. 2019; 93(1):149-161.","DOI":"10.1007\/s00204-018-2335-4"},{"key":"36753","doi-asserted-by":"crossref","unstructured":"Cominacini L, Pasini AF, Garbin U. Oxidized low density lipoprotein (ox-LDL) binding to ox-LDL receptor-1 in endothelial cells induces the activation of NF-kappaB through an increased production of intracellular reactive oxygen species. J Biol Chem. 2000; 275(17):12633-12638.","DOI":"10.1074\/jbc.275.17.12633"},{"key":"36754","doi-asserted-by":"crossref","unstructured":"Zhuang P, Zhang Y, He W. Dietary fats in relation to total and cause-specific mortality in a prospective cohort of 521 120 individuals with 16 years of follow-up. Circ Res. 2019; 124(5):757-768.","DOI":"10.1161\/CIRCRESAHA.118.314038"},{"key":"36755","doi-asserted-by":"crossref","unstructured":"Roy A, Jana M, Kundu M. HMG-CoA reductase inhibitors bind to PPAR\u03b1lpha to upregulate neurotrophin expression in the brain and improve memory in mice. Cell Metab. 2015; 22(2):253-265.","DOI":"10.1016\/j.cmet.2015.05.022"},{"key":"36756","doi-asserted-by":"crossref","unstructured":"Xu HE, Stanley TB, Montana VG. Structural basis for antagonist-mediated recruitment of nuclear co-repressors by PPAR\u03b1lpha. Nature. 2002; 415(6873):813-817.","DOI":"10.1038\/415813a"},{"key":"36757","doi-asserted-by":"crossref","unstructured":"Stojanovic A, Marjanovic JA, Brovkovych VM. A phosphoinositide 3-kinase-AKT-nitric oxide-cGMP signaling pathway in stimulating platelet secretion and aggregation. J Biol Chem. 2006; 281(24):16333-16339.","DOI":"10.1074\/jbc.M512378200"},{"key":"36758","doi-asserted-by":"crossref","unstructured":"O'Brien KA, Stojanovic-Terpo A, Hay N, Du X. An important role for Akt3 in platelet activation and thrombosis. Blood. 2011; 118(15):4215-4223.","DOI":"10.1182\/blood-2010-12-323204"},{"key":"36759","doi-asserted-by":"crossref","unstructured":"Kamiyama M, Shirai T, Tamura S. ASK1 facilitates tumor metastasis through phosphorylation of an ADP receptor P2Y12 in platelets. Cell Death Differ. 2017; 24(12):2066-2076.","DOI":"10.1038\/cdd.2017.114"},{"key":"36760","doi-asserted-by":"crossref","unstructured":"Teissier E, Nohara A, Chinetti G. Peroxisome proliferator-activated receptor alpha induces NADPH oxidase activity in macrophages, leading to the generation of LDL with PPAR-alpha activation properties. Circ Res. 2004; 95(12):1174-1182.","DOI":"10.1161\/01.RES.0000150594.95988.45"},{"key":"36761","doi-asserted-by":"crossref","unstructured":"Choo HJ, Saafir TB, Mkumba L, Wagner MB, Jobe SM. Mitochondrial calcium and reactive oxygen species regulate agonist-initiated platelet phosphatidylserine exposure. Arterioscler Thromb Vasc Biol. 2012; 32(12):2946-2955.","DOI":"10.1161\/ATVBAHA.112.300433"},{"key":"36762","doi-asserted-by":"crossref","unstructured":"Bakdash N, Williams MS. Spatially distinct production of reactive oxygen species regulates platelet activation. Free Radic Biol Med. 2008; 45(2):158-166.","DOI":"10.1016\/j.freeradbiomed.2008.03.021"},{"key":"36763","doi-asserted-by":"crossref","unstructured":"Liu Y, Hu M, Luo D. Class III PI3K positively regulates platelet activation and thrombosis via PI(3)P-directed function of NADPH oxidase. Arterioscler Thromb Vasc Biol. 2017; 37(11):2075-2086.","DOI":"10.1161\/ATVBAHA.117.309751"},{"key":"36764","doi-asserted-by":"crossref","unstructured":"Ricote M, Huang J, Fajas L. Expression of the peroxisome proliferator-activated receptor gamma (PPARgamma) in human atherosclerosis and regulation in macrophages by colony stimulating factors and oxidized low density lipoprotein. Proc Natl Acad Sci U S A. 1998; 95(13):7614-7619.","DOI":"10.1073\/pnas.95.13.7614"},{"key":"36765","doi-asserted-by":"crossref","unstructured":"Valet C, Batut A, Vauclard A. Adipocyte fatty acid transfer supports megakaryocyte maturation. Cell Rep. 2020; 32(1):107875.","DOI":"10.1016\/j.celrep.2020.107875"},{"key":"36766","doi-asserted-by":"crossref","unstructured":"Kelly KL, Reagan WJ, Sonnenberg GE. De novo lipogenesis is essential for platelet production in humans. Nat Metab. 2020; 2(10):1163-1178.","DOI":"10.1038\/s42255-020-00272-9"},{"key":"36767","doi-asserted-by":"crossref","unstructured":"Ide T, Shimano H, Yoshikawa T. Cross-talk between peroxisome proliferator-activated receptor (PPAR) alpha and liver X receptor (LXR) in nutritional regulation of fatty acid metabolism. II. LXRs suppress lipid degradation gene promoters through inhibition of PPAR signaling. Mol Endocrinol. 2003; 17(7):1255-1267.","DOI":"10.1210\/me.2002-0191"},{"key":"36768","doi-asserted-by":"crossref","unstructured":"Moraes LA, Spyridon M, Kaiser WJ. Non-genomic effects of PPARgamma ligands: inhibition of GPVI-stimulated platelet activation. J Thromb Haemost. 2010; 8(3):577-587.","DOI":"10.1111\/j.1538-7836.2009.03732.x"},{"key":"36769","doi-asserted-by":"crossref","unstructured":"Ali FY, Hall MG, Desvergne B, Warner TD, Mitchell JA. PPAR\u03b2eta\/delta agonists modulate platelet function via a mechanism involving PPAR receptors and specific association\/repression of PKCalpha--brief report. Arterioscler Thromb Vasc Biol. 2009; 29(11):1871-1873.","DOI":"10.1161\/ATVBAHA.109.193367"},{"key":"36770","doi-asserted-by":"crossref","unstructured":"Hu L, Chang L, Zhang Y. Platelets express activated P2Y12 receptor in patients with diabetes mellitus. Circulation. 2017; 136(9):817-833.","DOI":"10.1161\/CIRCULATIONAHA.116.026995"},{"key":"36771","doi-asserted-by":"crossref","unstructured":"Delerive P, De Bosscher K, Besnard S. Peroxisome proliferator-activated receptor alpha negatively regulates the vascular inflammatory gene response by negative cross-talk with transcription factors NF-kappaB and AP-1. J Biol Chem. 1999; 274(45):32048-32054.","DOI":"10.1074\/jbc.274.45.32048"},{"key":"36772","doi-asserted-by":"crossref","unstructured":"Devchand PR, Keller H, Peters JM, Vazquez M, Gonzalez FJ, Wahli W. The PPAR\u03b1lpha-leukotriene B4 pathway to inflammation control. Nature. 1996; 384(6604):39-43.","DOI":"10.1038\/384039a0"},{"key":"36773","doi-asserted-by":"crossref","unstructured":"Staels B, Koenig W, Habib A. Activation of human aortic smooth-muscle cells is inhibited by PPAR\u03b1lpha but not by PPARgamma activators. Nature. 1998; 393(6687):790-793.","DOI":"10.1038\/31701"},{"key":"36774","doi-asserted-by":"crossref","unstructured":"Inoue I, Shino K, Noji S, Awata T, Katayama S. Expression of peroxisome proliferator-activated receptor alpha (PPAR alpha) in primary cultures of human vascular endothelial cells. Biochem Biophys Res Commun. 1998; 246(2):370-374.","DOI":"10.1006\/bbrc.1998.8622"},{"key":"36775","doi-asserted-by":"crossref","unstructured":"Chinetti G, Gbaguidi FG, Griglio S. CLA-1\/SR-BI is expressed in atherosclerotic lesion macrophages and regulated by activators of peroxisome proliferator-activated receptors. Circulation. 2000; 101(20):2411-2417.","DOI":"10.1161\/01.CIR.101.20.2411"}],"container-title":["Haematologica"],"original-title":[],"link":[{"URL":"https:\/\/haematologica.org\/article\/download\/haematol.2021.279770\/73756","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/haematologica.org\/article\/download\/haematol.2021.279770\/74532","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/haematologica.org\/article\/download\/10420\/73756","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T10:00:28Z","timestamp":1794045628000},"score":1,"resource":{"primary":{"URL":"https:\/\/haematologica.org\/article\/view\/haematol.2021.279770"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,7]]},"references-count":50,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2022,6,1]]}},"URL":"https:\/\/doi.org\/10.3324\/haematol.2021.279770","relation":{},"ISSN":["1592-8721","0390-6078"],"issn-type":[{"value":"1592-8721","type":"electronic"},{"value":"0390-6078","type":"print"}],"subject":[],"published":{"date-parts":[[2021,10,7]]}}}